Capital Fund Management (CFM)’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.2M | Sell |
84,429
-23,710
| -22% | -$1.74M | 0.02% | 334 |
|
|
2025
Q1 | $12.4M | Sell |
108,139
-12,867
| -11% | -$1.47M | 0.04% | 176 |
|
|
2024
Q4 | $6.1M | Sell |
121,006
-28,991
| -19% | -$1.46M | 0.02% | 363 |
|
|
2024
Q3 | $6.94M | Buy |
149,997
+56,100
| +60% | +$2.6M | 0.02% | 284 |
|
|
2024
Q2 | $3.05M | Sell |
93,897
-39,282
| -29% | -$1.28M | 0.01% | 416 |
|
|
2024
Q1 | $3.35M | Buy |
133,179
+55,342
| +71% | +$1.39M | 0.01% | 387 |
|
|
2023
Q4 | $2.53M | Buy |
77,837
+12,637
| +19% | +$410K | 0.01% | 463 |
|
|
2023
Q3 | $1.78M | Buy |
65,200
+52,020
| +395% | +$1.42M | 0.01% | 467 |
|
|
2023
Q2 | $293K | Sell |
13,180
-7
| -0.1% | -$156 | ﹤0.01% | 584 |
|
|
2023
Q1 | $286K | Sell |
13,187
-5,538
| -30% | -$120K | ﹤0.01% | 531 |
|
|
2022
Q4 | $380K | Buy |
+18,725
| New | +$380K | ﹤0.01% | 498 |
|
|
2022
Q3 | – | Sell |
-18,594
| Closed | -$442K | – | 627 |
|
|
2022
Q2 | $442K | Buy |
+18,594
| New | +$442K | ﹤0.01% | 556 |
|
|
2021
Q1 | – | Sell |
-25,965
| Closed | -$679K | – | 605 |
|
|
2020
Q4 | $679K | Buy |
25,965
+9,705
| +60% | +$254K | 0.01% | 410 |
|
|
2020
Q3 | $283K | Buy |
+16,260
| New | +$283K | ﹤0.01% | 540 |
|
|
2020
Q2 | – | Sell |
-10,172
| Closed | -$121K | – | 610 |
|
|
2020
Q1 | $121K | Buy |
+10,172
| New | +$121K | ﹤0.01% | 799 |
|
|
2018
Q4 | – | Sell |
-540,818
| Closed | -$7.58M | – | 876 |
|
|
2018
Q3 | $7.58M | Buy |
540,818
+229,969
| +74% | +$3.22M | 0.04% | 242 |
|
|
2018
Q2 | $4.89M | Buy |
310,849
+143,801
| +86% | +$2.26M | 0.03% | 334 |
|
|
2018
Q1 | $2.75M | Buy |
+167,048
| New | +$2.75M | 0.02% | 434 |
|